Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$29.28 -0.57 (-1.91%)
At close: Sep 29, 2026 · 4:00 PM EDT

Amylyx Pharmaceuticals (AMLX) Total Current Liabilities (2021 - 2026)

Updated

Amylyx Pharmaceuticals (AMLX) reported Total Current Liabilities of $21.15 million for Q2 2026, down 1.3% from $21.42 million a year earlier but up 32.5% from the prior quarter.

Analysis

Amylyx Pharmaceuticals (AMLX) Total Current Liabilities (2021 - 2026) Analysis & Trends

At the end of FY2025, Amylyx Pharmaceuticals posted Total Current Liabilities of $22.69 million, down 20.1% from FY2024.

  • Total Current Liabilities has a four-year compound annual growth rate of 6.9% (FY2021 to FY2025).
  • By year, Total Current Liabilities came in at $28.41 million in FY2024 (-65.4%), $82.04 million in FY2023 (+76.0%), $46.61 million in FY2022 (+167.9%) and $17.4 million in FY2021.
  • Five-year quarterly Total Current Liabilities spans a low of $15.97 million in Q1 2026 and a high of $91.64 million in Q1 2024.
  • Year over year, Total Current Liabilities has now declined in each of the last seven quarters, with an average decline of 35.2% over the last eight quarters.
  • The high point for year-over-year Total Current Liabilities in five years was Q4 2022 (growth of 167.9%); the low point was Q1 2025 (a decline of 80.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $15.97 million (Q1 2026), $22.69 million (Q4 2025) and $25.79 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Amylyx Pharmaceuticals 3.32 Bn 3.32 Bn - 21.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.15 Mn
Mar 31, 2026 15.97 Mn
Dec 31, 2025 22.69 Mn
Sep 30, 2025 25.79 Mn
Jun 30, 2025 21.42 Mn
Mar 31, 2025 17.93 Mn
Dec 31, 2024 28.41 Mn
Sep 30, 2024 53.92 Mn
Jun 30, 2024 70.08 Mn
Mar 31, 2024 91.64 Mn
Dec 31, 2023 82.04 Mn
Sep 30, 2023 45.62 Mn
Jun 30, 2023 64.08 Mn
Mar 31, 2023 51.62 Mn
Dec 31, 2022 46.61 Mn
Sep 30, 2022 32.65 Mn
Jun 30, 2022 27.16 Mn
Mar 31, 2022 27.71 Mn
Dec 31, 2021 17.40 Mn
API Access

Amylyx Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=AMLX&period=max&api_key=YOUR_API_KEY